ANNOVIS BIO INC. COMM
1.2550
16-April-25 16:30:00
15 minutes delayed
Stocks
+0.0350
+2.87%
Today's range
1.1950 - 1.2899
ISIN
N/A
Source
NYSE
-
20 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024
27 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
30 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
24 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio to Participate in the 139th Yale CEO Summit
11 Dec 2023 13:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
Annovis Bio Appoints Andrew Walsh as Vice President Finance
01 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
-
27 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate Update
08 Nov 2023 17:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 08:02:38 By Nasdaq GlobeNewswire
-
Annovis Bio Announces First Quarter 2023 Financial Results and Provides Corporate Update
11 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit
11 Mar 2021 07:05:00 By Nasdaq GlobeNewswire
-
Annovis Bio to Present at the BIO CEO & Investor Digital Conference
16 Feb 2021 06:45:00 By Nasdaq GlobeNewswire